数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Gregg Lehman Director, Executive Chairman 70 10.95万美元 未持股 2017-05-22
David Dreyer Director 61 7.10万美元 未持股 2017-05-22
Ryan Morris Director 39 5.01万美元 未持股 2017-05-22
Joseph Whitters Director 59 6.85万美元 未持股 2017-05-22
Scott A. Shuda Director 51 0.33万美元 未持股 2017-05-22

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Gregg Lehman Director, Executive Chairman 70 10.95万美元 未持股 2017-05-22
Chris S. Downs Executive Vice President and Chief Financial Officer 39 未披露 未持股 2017-05-22
Trent N. Smith Executive Vice President, Chief Accounting Officer and Corporate Controller 48 未披露 未持股 2017-05-22
Rich DiIorio Executive Vice President and General Manager 42 未披露 未持股 2017-05-22
Janet Skonieczny Executive Vice President, Chief Operating Officer, Compliance Officer and Privacy Officer,Member of Office of the President 58 40.72万美元 未持股 2017-05-22
Mike McReynolds Executive Vice President and Chief Information Officer 48 未披露 未持股 2017-05-22

董事简历

中英对照 |  中文 |  英文
Gregg Lehman

Gregg Lehman,他曾一直担任EB Employee Solutions公司的首席执行官(2014年5月以来)。他此前曾担任MGC Diagnostics Corporation(领先的呼吸诊断公司)的总裁兼首席执行官(从2011年7月到2014年5月)。他曾担任Health Fitness Corporation(人口健康管理公司,位于明尼阿波利斯)的总裁兼首席执行官(从2007年到2010年)。他曾担任医疗和教育行业的多种高级执行和行政职务,包括担任INSPIRIS公司(那什维尔专业保健医疗管理公司)的总裁兼首席执行官。他也曾担任Gordian Health Solutions公司(健康管理公司)的总裁兼首席执行官,以及the National Business Coalition on Health(NBGH,位于华盛顿特区)的总裁兼首席执行官,以及印第安纳州泰勒大学(Taylor University)的校长。他目前任职于Care Continuum Alliance(位于华盛顿)的执行委员会,也曾任职医疗采购机构,包括Academy Health、the eHealth Initiative、the National Quality Forum、the National Patient Safety Foundation,以及其它促进价值采购和市场化改革的采购/质量组织 。他持有Purdue University的高等教育管理博士学位和理学硕士学位(辅修金融和经济),以及Indiana University的工商管理和营销学士学位。


Gregg Lehman has been a member of the Company's Board of Directors since May 8 2014 and has served as Executive Chairman and head of the Office of the President, as described under "Board of Directors and Committees of the Board of Directors" below, since May 18 2017. Dr. Lehman is a nationally recognized leader in population health management and has more than 28 years' experience in the health care industry. Dr. Lehman has served as Chief Executive Officer of EB Employee Solutions, LLC, a company that provides a fully integrated employer portal that includes health benefit cost reduction strategies and a "high tech, smart touch" wellness program. Dr. Lehman was previously President and Chief Executive Officer of MGC Diagnostics Corporation, a leading cardio-respiratory diagnostic company from July 2011 until May 2014. Dr. Lehman served as President and Chief Executive Officer of Health Fitness Corporation, a population health management company based in Minneapolis, MN, from 2007 through 2010. Dr. Lehman has held numerous senior-level executive and governance positions in the medical and education industries including President and Chief Executive Officer of INSPIRIS, Inc., a Nashville-based specialty care medical management company. Dr. Lehman also was President and Chief Executive Officer of Gordian Health Solutions, Inc., a health management company, and President and Chief Executive Officer of the National Business Coalition on Health NBGH in Washington, D.C., and as President of Taylor University in Indiana. Dr. Lehman has worked with the Health Care Purchasing Institute through Academy Health, the eHealth Initiative, the National Quality Forum, the National Patient Safety Foundation, and other purchasing/quality organizations that promote value-based purchasing and market-based reform. Dr. Lehman has a Doctorate and a Master of Science degree in higher education administration, with a minor in finance and economics from Purdue University and a Bachelor of Science in business management and marketing from Indiana University.
Gregg Lehman,他曾一直担任EB Employee Solutions公司的首席执行官(2014年5月以来)。他此前曾担任MGC Diagnostics Corporation(领先的呼吸诊断公司)的总裁兼首席执行官(从2011年7月到2014年5月)。他曾担任Health Fitness Corporation(人口健康管理公司,位于明尼阿波利斯)的总裁兼首席执行官(从2007年到2010年)。他曾担任医疗和教育行业的多种高级执行和行政职务,包括担任INSPIRIS公司(那什维尔专业保健医疗管理公司)的总裁兼首席执行官。他也曾担任Gordian Health Solutions公司(健康管理公司)的总裁兼首席执行官,以及the National Business Coalition on Health(NBGH,位于华盛顿特区)的总裁兼首席执行官,以及印第安纳州泰勒大学(Taylor University)的校长。他目前任职于Care Continuum Alliance(位于华盛顿)的执行委员会,也曾任职医疗采购机构,包括Academy Health、the eHealth Initiative、the National Quality Forum、the National Patient Safety Foundation,以及其它促进价值采购和市场化改革的采购/质量组织 。他持有Purdue University的高等教育管理博士学位和理学硕士学位(辅修金融和经济),以及Indiana University的工商管理和营销学士学位。
Gregg Lehman has been a member of the Company's Board of Directors since May 8 2014 and has served as Executive Chairman and head of the Office of the President, as described under "Board of Directors and Committees of the Board of Directors" below, since May 18 2017. Dr. Lehman is a nationally recognized leader in population health management and has more than 28 years' experience in the health care industry. Dr. Lehman has served as Chief Executive Officer of EB Employee Solutions, LLC, a company that provides a fully integrated employer portal that includes health benefit cost reduction strategies and a "high tech, smart touch" wellness program. Dr. Lehman was previously President and Chief Executive Officer of MGC Diagnostics Corporation, a leading cardio-respiratory diagnostic company from July 2011 until May 2014. Dr. Lehman served as President and Chief Executive Officer of Health Fitness Corporation, a population health management company based in Minneapolis, MN, from 2007 through 2010. Dr. Lehman has held numerous senior-level executive and governance positions in the medical and education industries including President and Chief Executive Officer of INSPIRIS, Inc., a Nashville-based specialty care medical management company. Dr. Lehman also was President and Chief Executive Officer of Gordian Health Solutions, Inc., a health management company, and President and Chief Executive Officer of the National Business Coalition on Health NBGH in Washington, D.C., and as President of Taylor University in Indiana. Dr. Lehman has worked with the Health Care Purchasing Institute through Academy Health, the eHealth Initiative, the National Quality Forum, the National Patient Safety Foundation, and other purchasing/quality organizations that promote value-based purchasing and market-based reform. Dr. Lehman has a Doctorate and a Master of Science degree in higher education administration, with a minor in finance and economics from Purdue University and a Bachelor of Science in business management and marketing from Indiana University.
David Dreyer

2008年4月以来,David Dreyer担任董事会成员。2010年10月以来,他担任Patient Safety Technologies OTCBB: PSTX的首席财务官、首席运营官和部长。之前,从2009年8月到2010年9月,他担任Alphastaff集团的首席财务官,一家人力资源外包公司。从2004年9月到2009年8月,他担任AMN Healthcare Services的首席财务官和首席财务官。从2006年到2009年8月,他担任财务总监。在他的任期内,AMN成为医生、护士和盟军旅行等医疗关注的领导者,4年营收12亿美元。从1997年到2004年,他担任Sicor的首席财务官和首席财务官,一家符合药品制造商,其目标市场主要是美国、意大利、墨西哥、立陶宛、中国和瑞士,其被Teva Pharmaceutical收购。2004年1月,他负责将Sicor公司以34亿美元的价格出售给Teva Pharmaceutical公司。加入Sicor公司之前,他在相关制药行业担任高级财务管理职位,他在Elan、Athena Neurosciences and Syntex公司工作。他是一名加州注册会计师。


David Dreyer has been a member of the Company's Board of Directors since April 2008 and has served as a member of the Office of the President, as described under "Board of Directors and Committees of the Board of Directors" below, since May 18 2017. Mr. Dreyer currently serves as Chief Financial Officer of Prolacta Biosciences, Inc. a privately held, life sciences company dedicated to improving the quality of life for newly born babies through creating and marketing specialty formulations made from human milk. From March 2015 through January 2017 Mr. Dreyer served as Chief Financial Officer of BIOLASE, Inc. NASDAQ:BIOL, a medical device company that develops, manufactures, and markets lasers used in the dental and medical fields. From October 2010 to March 2015 Mr. Dreyer served as Chief Financial Officer, Chief Operating Officer and Secretary of Patient Safety Technologies, which develops, markets and sells healthcare products to hospitals for ensuring surgical safety, and was previously a public reporting company (OTC: PSTX), and since March 2014 became a subsidiary of Stryker Corporation (NYSE: SYK). Previously, Mr. Dreyer was Chief Financial Officer of Alphastaff Group, Inc., a human resource outsourcing company, from August 2009 to September 2010. From September 2004 to August 2009 Mr. Dreyer served as Chief Financial Officer and Chief Accounting Officer of AMN Healthcare Services, Inc. (NYSE: AHS), which provided healthcare staffing for physicians, travel nurses, and allied travel. From 1997 through 2004 Mr. Dreyer served as Chief Financial Officer and Chief Accounting Officer of Sicor, Inc. (formerly Nasdaq: SCRI), a manufacturer of complex pharmaceuticals with operations in the United States and internationally, which was acquired by Teva Pharmaceutical Limited in January 2004. Prior to joining Sicor, Mr. Dreyer served in related senior financial management positions within the pharmaceutical industry, working for Elan Corporation plc, Athena Neurosciences and Syntex Corporation. Mr. Dreyer is a Certified Public Accountant in California. Since April 2008 Mr. Dreyer has also been a director of Diplomat Pharmacy, Inc. (NYSE:DPLO), the leading independent specialty pharmacy in the U.S., and currently serves as chairman of both its Audit and Compensation Committees.
2008年4月以来,David Dreyer担任董事会成员。2010年10月以来,他担任Patient Safety Technologies OTCBB: PSTX的首席财务官、首席运营官和部长。之前,从2009年8月到2010年9月,他担任Alphastaff集团的首席财务官,一家人力资源外包公司。从2004年9月到2009年8月,他担任AMN Healthcare Services的首席财务官和首席财务官。从2006年到2009年8月,他担任财务总监。在他的任期内,AMN成为医生、护士和盟军旅行等医疗关注的领导者,4年营收12亿美元。从1997年到2004年,他担任Sicor的首席财务官和首席财务官,一家符合药品制造商,其目标市场主要是美国、意大利、墨西哥、立陶宛、中国和瑞士,其被Teva Pharmaceutical收购。2004年1月,他负责将Sicor公司以34亿美元的价格出售给Teva Pharmaceutical公司。加入Sicor公司之前,他在相关制药行业担任高级财务管理职位,他在Elan、Athena Neurosciences and Syntex公司工作。他是一名加州注册会计师。
David Dreyer has been a member of the Company's Board of Directors since April 2008 and has served as a member of the Office of the President, as described under "Board of Directors and Committees of the Board of Directors" below, since May 18 2017. Mr. Dreyer currently serves as Chief Financial Officer of Prolacta Biosciences, Inc. a privately held, life sciences company dedicated to improving the quality of life for newly born babies through creating and marketing specialty formulations made from human milk. From March 2015 through January 2017 Mr. Dreyer served as Chief Financial Officer of BIOLASE, Inc. NASDAQ:BIOL, a medical device company that develops, manufactures, and markets lasers used in the dental and medical fields. From October 2010 to March 2015 Mr. Dreyer served as Chief Financial Officer, Chief Operating Officer and Secretary of Patient Safety Technologies, which develops, markets and sells healthcare products to hospitals for ensuring surgical safety, and was previously a public reporting company (OTC: PSTX), and since March 2014 became a subsidiary of Stryker Corporation (NYSE: SYK). Previously, Mr. Dreyer was Chief Financial Officer of Alphastaff Group, Inc., a human resource outsourcing company, from August 2009 to September 2010. From September 2004 to August 2009 Mr. Dreyer served as Chief Financial Officer and Chief Accounting Officer of AMN Healthcare Services, Inc. (NYSE: AHS), which provided healthcare staffing for physicians, travel nurses, and allied travel. From 1997 through 2004 Mr. Dreyer served as Chief Financial Officer and Chief Accounting Officer of Sicor, Inc. (formerly Nasdaq: SCRI), a manufacturer of complex pharmaceuticals with operations in the United States and internationally, which was acquired by Teva Pharmaceutical Limited in January 2004. Prior to joining Sicor, Mr. Dreyer served in related senior financial management positions within the pharmaceutical industry, working for Elan Corporation plc, Athena Neurosciences and Syntex Corporation. Mr. Dreyer is a Certified Public Accountant in California. Since April 2008 Mr. Dreyer has also been a director of Diplomat Pharmacy, Inc. (NYSE:DPLO), the leading independent specialty pharmacy in the U.S., and currently serves as chairman of both its Audit and Compensation Committees.
Ryan Morris

Ryan Morris自2012年4月24日担任公司董事会成员。他是Meson Capital Partners的管理成员,一家旧金山的投资公司,他于2009年2月成立该公司。他担任公司董事会的执行主席。2013年12月以来,目前,他担任Sevcon的董事会成员,(纽约证交所)。2012年10月以来,他担任卢卡斯能源董事成员(纽约证交所)。2012年12月至2012年11月,他担任董事会主席。从2011年6月到2012年7月,他担任权益委员会成员,负责HearUSA的股东价值最大化,纽约证交所Amex上市的公司于Chapter 11破产,这已经清算其资产和停止操作。成立Meson 之前,2008年7月,他成立了VideoNote公司,一家小型和收费教育软件公司,其客户包括康奈尔大学和世界银行。他继续担任其首席执行官。他拥有康奈尔大学研究与信息工程学院的科学与工程硕士学位和特许金融分析师的名称。


Ryan Morris has been a member of the Company’s Board of Directors since April 24 2012. Mr. Morris is President of Meson Capital Partners LLC “Meson LLC”, a San Francisco-based investment manager, which he founded in February 2009. Mr. Morris served as Chairman of the Company from April 2012 to May 2015 and was Executive Chairman from April 2012 through May 2014. Mr. Morris has served on the board of Sevcon, Inc. (NYSE MKT: SEV) since December 2013 and served as its Executive Chairman from July 2016 to December 2016. He has served on the Board of Directors of Trans-Lux Corporation (OTC Pink: TNLX) since April 2016 and previously served on the Board of Directors of Lucas Energy (NYSE MKT: LEI) from October 2012 to October 2014 and served as Chairman of the Board from December 2012 to November 2013. From June 2011 through July 2012 Mr. Morris served as a member of the Equity Committee responsible for maximizing value to the stockholders of the former HearUSA, Inc. Prior to founding Meson LLC, in July 2008 he co-founded VideoNote LLC, a small and profitable educational software company with customers including Cornell University and The World Bank. Mr. Morris has a Bachelor of Science and Masters of Engineering degree in Operations Research & Information Engineering from Cornell University, and holds the Chartered Financial Analyst designation.
Ryan Morris自2012年4月24日担任公司董事会成员。他是Meson Capital Partners的管理成员,一家旧金山的投资公司,他于2009年2月成立该公司。他担任公司董事会的执行主席。2013年12月以来,目前,他担任Sevcon的董事会成员,(纽约证交所)。2012年10月以来,他担任卢卡斯能源董事成员(纽约证交所)。2012年12月至2012年11月,他担任董事会主席。从2011年6月到2012年7月,他担任权益委员会成员,负责HearUSA的股东价值最大化,纽约证交所Amex上市的公司于Chapter 11破产,这已经清算其资产和停止操作。成立Meson 之前,2008年7月,他成立了VideoNote公司,一家小型和收费教育软件公司,其客户包括康奈尔大学和世界银行。他继续担任其首席执行官。他拥有康奈尔大学研究与信息工程学院的科学与工程硕士学位和特许金融分析师的名称。
Ryan Morris has been a member of the Company’s Board of Directors since April 24 2012. Mr. Morris is President of Meson Capital Partners LLC “Meson LLC”, a San Francisco-based investment manager, which he founded in February 2009. Mr. Morris served as Chairman of the Company from April 2012 to May 2015 and was Executive Chairman from April 2012 through May 2014. Mr. Morris has served on the board of Sevcon, Inc. (NYSE MKT: SEV) since December 2013 and served as its Executive Chairman from July 2016 to December 2016. He has served on the Board of Directors of Trans-Lux Corporation (OTC Pink: TNLX) since April 2016 and previously served on the Board of Directors of Lucas Energy (NYSE MKT: LEI) from October 2012 to October 2014 and served as Chairman of the Board from December 2012 to November 2013. From June 2011 through July 2012 Mr. Morris served as a member of the Equity Committee responsible for maximizing value to the stockholders of the former HearUSA, Inc. Prior to founding Meson LLC, in July 2008 he co-founded VideoNote LLC, a small and profitable educational software company with customers including Cornell University and The World Bank. Mr. Morris has a Bachelor of Science and Masters of Engineering degree in Operations Research & Information Engineering from Cornell University, and holds the Chartered Financial Analyst designation.
Joseph Whitters

自2012年4月24日,Joseph Whitters担任公司董事会成员。自2005年以来,他担任Frazier Health Care公司的医疗顾问,一家风险投资公司。从1986年到2005年1月,他在第一健康集团公司从事不同工作,NASDAQ: FHCC,一家管理医疗公司,其市值近20亿美元,向集团健康、员工薪酬和国家机构市场提供服务,包括首席财务官和执行副总裁。1986年加入First Health公司之前,他担任United HealthCare Corp最大子公司的财务总监。2013年1月,他加入了PRGX Global董事会,一家商业服务公司,他同样也担任薪酬委员会和审计委员会成员。之前,他担任多家上市公司的董事会和审计委员会成员,包括Omnicell (NASDAQ: OMCL), Mentor Corporation (formerly NYSE: MNT), Solexa (formerly NASDAQ: SLXA), and Luminent Mortgage (formerly NYSE: LUM)。他担任多家私人公司董事会成员或者顾问,包括PCI包装公司的审计委员会主席。他在Peat Marwick从事公众会计开始他的职业生涯。他拥有爱荷华州路德大学会计学士学位。他是一名注册会计师。


Joseph Whitters has been a member of the Company's Board of Directors since April 24 2012. Mr. Whitters has been an Advisor to Frazier Health Care, a venture capital and private equity firm, since 2005. From 1986 to January 2005 Mr. Whitters was employed in various capacities with First Health Group Corp. formerly NASDAQ: FHCC, a nearly $2 billion market capitalization managed healthcare company serving the group health, workers compensation, and state agency markets, including as Chief Financial Officer and Executive Vice President. Prior to joining First Health in 1986 he served as Controller for United HealthCare Corp. In January 2013 he joined the board of directors of PRGX Global, Inc., a business service enterprise, where he also serves on the Compensation Committee and Audit Committee. In 2016 Mr. Whitters served on the board of directors of Air Methods Corporation, an air medical transportation company that was sold in April 2017. Previously, he served on the boards of directors and the audit committees of various public companies including Omnicell (NASDAQ: OMCL), Mentor Corporation (formerly NYSE: MNT), Solexa (formerly NASDAQ: SLXA), and Luminent Mortgage (formerly NYSE: LUM). Mr. Whitters has also been an advisor or board member with several private companies. Mr. Whitters began his career in public accounting with Peat Marwick and has a Bachelor's of Arts in accounting degree from Luther College in Iowa. Mr. Whitters is a certified public accountant.
自2012年4月24日,Joseph Whitters担任公司董事会成员。自2005年以来,他担任Frazier Health Care公司的医疗顾问,一家风险投资公司。从1986年到2005年1月,他在第一健康集团公司从事不同工作,NASDAQ: FHCC,一家管理医疗公司,其市值近20亿美元,向集团健康、员工薪酬和国家机构市场提供服务,包括首席财务官和执行副总裁。1986年加入First Health公司之前,他担任United HealthCare Corp最大子公司的财务总监。2013年1月,他加入了PRGX Global董事会,一家商业服务公司,他同样也担任薪酬委员会和审计委员会成员。之前,他担任多家上市公司的董事会和审计委员会成员,包括Omnicell (NASDAQ: OMCL), Mentor Corporation (formerly NYSE: MNT), Solexa (formerly NASDAQ: SLXA), and Luminent Mortgage (formerly NYSE: LUM)。他担任多家私人公司董事会成员或者顾问,包括PCI包装公司的审计委员会主席。他在Peat Marwick从事公众会计开始他的职业生涯。他拥有爱荷华州路德大学会计学士学位。他是一名注册会计师。
Joseph Whitters has been a member of the Company's Board of Directors since April 24 2012. Mr. Whitters has been an Advisor to Frazier Health Care, a venture capital and private equity firm, since 2005. From 1986 to January 2005 Mr. Whitters was employed in various capacities with First Health Group Corp. formerly NASDAQ: FHCC, a nearly $2 billion market capitalization managed healthcare company serving the group health, workers compensation, and state agency markets, including as Chief Financial Officer and Executive Vice President. Prior to joining First Health in 1986 he served as Controller for United HealthCare Corp. In January 2013 he joined the board of directors of PRGX Global, Inc., a business service enterprise, where he also serves on the Compensation Committee and Audit Committee. In 2016 Mr. Whitters served on the board of directors of Air Methods Corporation, an air medical transportation company that was sold in April 2017. Previously, he served on the boards of directors and the audit committees of various public companies including Omnicell (NASDAQ: OMCL), Mentor Corporation (formerly NYSE: MNT), Solexa (formerly NASDAQ: SLXA), and Luminent Mortgage (formerly NYSE: LUM). Mr. Whitters has also been an advisor or board member with several private companies. Mr. Whitters began his career in public accounting with Peat Marwick and has a Bachelor's of Arts in accounting degree from Luther College in Iowa. Mr. Whitters is a certified public accountant.
Scott A. Shuda

Scott A. Shuda,自2012年12月起,他一直担任公司董事。他是BlueLine Partners, LLC(一个专注于上市的技术和医疗保健公司的投资公司)的董事总经理和联合创始人。自2010年至2011年,他是MGC Diagnostics Corporation(即以前的Angeion Corporation)的董事和审计委员会成员。在2004年4月联合创立BlueLine Partners之前,他是Vicinity Corporation(一个互联网搜索公司,2004年上市,2002年被Microsoft收购)的总法律顾问。在Vicinity任职之前,他在美国加州和纽约进行法律实践,最近的是在 Latham & Watkins LLP的美国硅谷办公室工作。他持有Georgetown University的法律博士学士学位,以及Georgetown University的工商管理学硕士学位。他接受的教育以及他的经验为他任职于我们的薪酬委员会提供了必要的行政补偿经验。


Scott A. Shuda has served as a director of the Company since December 2012. Mr. Shuda is the Managing Director and Co-founder of BlueLine Partners, LLC, an investment firm that focuses on publicly listed technology and healthcare companies. Mr. Shuda served as a director and Audit Committee member of MGC Diagnostics Corporation formerly Angeion Corporation, a global medical technology company from 2010 to 2011. Prior to co-founding BlueLine Partners in April 2004 Mr. Shuda was General Counsel to Vicinity Corporation, an internet search company that went public in 2000 and was acquired by Microsoft in 2002. Prior to his employment with Vicinity, Mr. Shuda practiced law in California and New York, most recently in the Silicon Valley office of Latham & Watkins LLP. Mr. Shuda holds a J.D. from Georgetown University and an M.B.A. from Georgetown University.
Scott A. Shuda,自2012年12月起,他一直担任公司董事。他是BlueLine Partners, LLC(一个专注于上市的技术和医疗保健公司的投资公司)的董事总经理和联合创始人。自2010年至2011年,他是MGC Diagnostics Corporation(即以前的Angeion Corporation)的董事和审计委员会成员。在2004年4月联合创立BlueLine Partners之前,他是Vicinity Corporation(一个互联网搜索公司,2004年上市,2002年被Microsoft收购)的总法律顾问。在Vicinity任职之前,他在美国加州和纽约进行法律实践,最近的是在 Latham & Watkins LLP的美国硅谷办公室工作。他持有Georgetown University的法律博士学士学位,以及Georgetown University的工商管理学硕士学位。他接受的教育以及他的经验为他任职于我们的薪酬委员会提供了必要的行政补偿经验。
Scott A. Shuda has served as a director of the Company since December 2012. Mr. Shuda is the Managing Director and Co-founder of BlueLine Partners, LLC, an investment firm that focuses on publicly listed technology and healthcare companies. Mr. Shuda served as a director and Audit Committee member of MGC Diagnostics Corporation formerly Angeion Corporation, a global medical technology company from 2010 to 2011. Prior to co-founding BlueLine Partners in April 2004 Mr. Shuda was General Counsel to Vicinity Corporation, an internet search company that went public in 2000 and was acquired by Microsoft in 2002. Prior to his employment with Vicinity, Mr. Shuda practiced law in California and New York, most recently in the Silicon Valley office of Latham & Watkins LLP. Mr. Shuda holds a J.D. from Georgetown University and an M.B.A. from Georgetown University.

高管简历

中英对照 |  中文 |  英文
Gregg Lehman

Gregg Lehman,他曾一直担任EB Employee Solutions公司的首席执行官(2014年5月以来)。他此前曾担任MGC Diagnostics Corporation(领先的呼吸诊断公司)的总裁兼首席执行官(从2011年7月到2014年5月)。他曾担任Health Fitness Corporation(人口健康管理公司,位于明尼阿波利斯)的总裁兼首席执行官(从2007年到2010年)。他曾担任医疗和教育行业的多种高级执行和行政职务,包括担任INSPIRIS公司(那什维尔专业保健医疗管理公司)的总裁兼首席执行官。他也曾担任Gordian Health Solutions公司(健康管理公司)的总裁兼首席执行官,以及the National Business Coalition on Health(NBGH,位于华盛顿特区)的总裁兼首席执行官,以及印第安纳州泰勒大学(Taylor University)的校长。他目前任职于Care Continuum Alliance(位于华盛顿)的执行委员会,也曾任职医疗采购机构,包括Academy Health、the eHealth Initiative、the National Quality Forum、the National Patient Safety Foundation,以及其它促进价值采购和市场化改革的采购/质量组织 。他持有Purdue University的高等教育管理博士学位和理学硕士学位(辅修金融和经济),以及Indiana University的工商管理和营销学士学位。


Gregg Lehman has been a member of the Company's Board of Directors since May 8 2014 and has served as Executive Chairman and head of the Office of the President, as described under "Board of Directors and Committees of the Board of Directors" below, since May 18 2017. Dr. Lehman is a nationally recognized leader in population health management and has more than 28 years' experience in the health care industry. Dr. Lehman has served as Chief Executive Officer of EB Employee Solutions, LLC, a company that provides a fully integrated employer portal that includes health benefit cost reduction strategies and a "high tech, smart touch" wellness program. Dr. Lehman was previously President and Chief Executive Officer of MGC Diagnostics Corporation, a leading cardio-respiratory diagnostic company from July 2011 until May 2014. Dr. Lehman served as President and Chief Executive Officer of Health Fitness Corporation, a population health management company based in Minneapolis, MN, from 2007 through 2010. Dr. Lehman has held numerous senior-level executive and governance positions in the medical and education industries including President and Chief Executive Officer of INSPIRIS, Inc., a Nashville-based specialty care medical management company. Dr. Lehman also was President and Chief Executive Officer of Gordian Health Solutions, Inc., a health management company, and President and Chief Executive Officer of the National Business Coalition on Health NBGH in Washington, D.C., and as President of Taylor University in Indiana. Dr. Lehman has worked with the Health Care Purchasing Institute through Academy Health, the eHealth Initiative, the National Quality Forum, the National Patient Safety Foundation, and other purchasing/quality organizations that promote value-based purchasing and market-based reform. Dr. Lehman has a Doctorate and a Master of Science degree in higher education administration, with a minor in finance and economics from Purdue University and a Bachelor of Science in business management and marketing from Indiana University.
Gregg Lehman,他曾一直担任EB Employee Solutions公司的首席执行官(2014年5月以来)。他此前曾担任MGC Diagnostics Corporation(领先的呼吸诊断公司)的总裁兼首席执行官(从2011年7月到2014年5月)。他曾担任Health Fitness Corporation(人口健康管理公司,位于明尼阿波利斯)的总裁兼首席执行官(从2007年到2010年)。他曾担任医疗和教育行业的多种高级执行和行政职务,包括担任INSPIRIS公司(那什维尔专业保健医疗管理公司)的总裁兼首席执行官。他也曾担任Gordian Health Solutions公司(健康管理公司)的总裁兼首席执行官,以及the National Business Coalition on Health(NBGH,位于华盛顿特区)的总裁兼首席执行官,以及印第安纳州泰勒大学(Taylor University)的校长。他目前任职于Care Continuum Alliance(位于华盛顿)的执行委员会,也曾任职医疗采购机构,包括Academy Health、the eHealth Initiative、the National Quality Forum、the National Patient Safety Foundation,以及其它促进价值采购和市场化改革的采购/质量组织 。他持有Purdue University的高等教育管理博士学位和理学硕士学位(辅修金融和经济),以及Indiana University的工商管理和营销学士学位。
Gregg Lehman has been a member of the Company's Board of Directors since May 8 2014 and has served as Executive Chairman and head of the Office of the President, as described under "Board of Directors and Committees of the Board of Directors" below, since May 18 2017. Dr. Lehman is a nationally recognized leader in population health management and has more than 28 years' experience in the health care industry. Dr. Lehman has served as Chief Executive Officer of EB Employee Solutions, LLC, a company that provides a fully integrated employer portal that includes health benefit cost reduction strategies and a "high tech, smart touch" wellness program. Dr. Lehman was previously President and Chief Executive Officer of MGC Diagnostics Corporation, a leading cardio-respiratory diagnostic company from July 2011 until May 2014. Dr. Lehman served as President and Chief Executive Officer of Health Fitness Corporation, a population health management company based in Minneapolis, MN, from 2007 through 2010. Dr. Lehman has held numerous senior-level executive and governance positions in the medical and education industries including President and Chief Executive Officer of INSPIRIS, Inc., a Nashville-based specialty care medical management company. Dr. Lehman also was President and Chief Executive Officer of Gordian Health Solutions, Inc., a health management company, and President and Chief Executive Officer of the National Business Coalition on Health NBGH in Washington, D.C., and as President of Taylor University in Indiana. Dr. Lehman has worked with the Health Care Purchasing Institute through Academy Health, the eHealth Initiative, the National Quality Forum, the National Patient Safety Foundation, and other purchasing/quality organizations that promote value-based purchasing and market-based reform. Dr. Lehman has a Doctorate and a Master of Science degree in higher education administration, with a minor in finance and economics from Purdue University and a Bachelor of Science in business management and marketing from Indiana University.
Chris S. Downs

ChrisS.Downs自2016年8月起担任公司执行Vice President和临时首席财务官,并自2017年5月18日起担任总裁办公室成员,如上文“董事会和董事会委员会”所述。在被任命为执行Vice President和临时首席财务官之前,唐斯先生自2013年10月起担任公司Vice President和财务主管,自2011年6月起担任财务总监。在加入该公司之前,唐斯先生曾于2007年至2011年担任马伦集团有限公司并购集团的Vice President,并于2005年至2006年担任Alterity Partners LLC并购集团的合伙人。Downs还从2002年到2004年担任Citigroup全球企业和投资银行分析师。Downs先生在西点军校(U.S.Military Academy at West Point)获得经济学学士学位,在哥伦比亚商学院(Columbia Business School)获得工商管理硕士学位,在休斯敦-克利尔湖大学(University of Houston-Clear Lake)获得会计学硕士学位。Downs先生拥有注册财务专业CTP和注册财务规划与分析专业(FP&A)的专业认证。


Chris S. Downs has served as the Company's Executive Vice President and Interim Chief Financial Officer since August 2016 and has served as a member of the Office of the President, as described under "Board of Directors and Committees of the Board of Directors" above, since May 18 2017. Prior to his appointment as Executive Vice President and Interim Chief Financial Officer, Mr. Downs served as the Company's Vice President and Treasurer since October 2013 and as Director of Finance from June 2011. Prior to joining the Company, Mr. Downs served Maren Group LLC as a Vice President in its Mergers and Acquisitions Group from 2007 until 2011 and Alterity Partners LLC as an Associate in its Mergers and Acquisitions Group from 2005 until 2006. Mr. Downs also worked as an Analyst at Citigroup's Global Corporate and Investment Bank from 2002 until 2004. Mr. Downs holds a B.S. in Economics from the U.S. Military Academy at West Point, an M.B.A. from Columbia Business School and an M.S. in Accounting from the University of Houston-Clear Lake. Mr. Downs holds professional certifications as a Certified Treasury Professional CTP and Certified Financial Planning & Analysis Professional (FP&A).
ChrisS.Downs自2016年8月起担任公司执行Vice President和临时首席财务官,并自2017年5月18日起担任总裁办公室成员,如上文“董事会和董事会委员会”所述。在被任命为执行Vice President和临时首席财务官之前,唐斯先生自2013年10月起担任公司Vice President和财务主管,自2011年6月起担任财务总监。在加入该公司之前,唐斯先生曾于2007年至2011年担任马伦集团有限公司并购集团的Vice President,并于2005年至2006年担任Alterity Partners LLC并购集团的合伙人。Downs还从2002年到2004年担任Citigroup全球企业和投资银行分析师。Downs先生在西点军校(U.S.Military Academy at West Point)获得经济学学士学位,在哥伦比亚商学院(Columbia Business School)获得工商管理硕士学位,在休斯敦-克利尔湖大学(University of Houston-Clear Lake)获得会计学硕士学位。Downs先生拥有注册财务专业CTP和注册财务规划与分析专业(FP&A)的专业认证。
Chris S. Downs has served as the Company's Executive Vice President and Interim Chief Financial Officer since August 2016 and has served as a member of the Office of the President, as described under "Board of Directors and Committees of the Board of Directors" above, since May 18 2017. Prior to his appointment as Executive Vice President and Interim Chief Financial Officer, Mr. Downs served as the Company's Vice President and Treasurer since October 2013 and as Director of Finance from June 2011. Prior to joining the Company, Mr. Downs served Maren Group LLC as a Vice President in its Mergers and Acquisitions Group from 2007 until 2011 and Alterity Partners LLC as an Associate in its Mergers and Acquisitions Group from 2005 until 2006. Mr. Downs also worked as an Analyst at Citigroup's Global Corporate and Investment Bank from 2002 until 2004. Mr. Downs holds a B.S. in Economics from the U.S. Military Academy at West Point, an M.B.A. from Columbia Business School and an M.S. in Accounting from the University of Houston-Clear Lake. Mr. Downs holds professional certifications as a Certified Treasury Professional CTP and Certified Financial Planning & Analysis Professional (FP&A).
Trent N. Smith

TrentN.Smith自2016年8月起担任公司执行Vice President兼首席会计官。在2016年8月之前,史密斯先生担任公司的Vice President兼公司财务总监,并继续担任公司财务总监。加入公司之前,Smith从2010年到2011年担任Syncreon Holdings外部报告主管,在此之前,从2006年到2010年担任Champion Enterprises会计和财务报告主管。在Smith&8217;先生的职业生涯早期,他曾于2005年至2006年担任Dura Automotive的外部财务报告总监,并于1999年至2005年担任Valeo,Inc.的内部控制/财务总监。在1999年之前,Smith先生在德勤会计师事务所(Deloitte&Touche,LLP)担任了三年的审计师,并在美国海军任职四年。Smith先生拥有伊利诺伊大学(University of Illinois)会计学理学学士学位,并持有注册会计师执照。


Trent N. Smith has served as the Company’s Executive Vice President and Chief Accounting Officer since August 2016. Prior to August 2016 Mr. Smith served as the Company’s Vice President and Corporate Controller, and he continues to serve as Corporate Controller. Prior to joining the Company, Mr. Smith served Syncreon Holdings from 2010 through 2011 as Director of External Reporting, and prior to that served Champion Enterprises as Director of Accounting and Financial Reporting from 2006 until 2010. Earlier in Mr. Smith’s career, he served as Director of External Financial Reporting for Dura Automotive from 2005 until 2006 and Valeo, Inc. as Director of Internal Controls/Finance from 1999 until 2005. Prior to 1999 Mr. Smith worked as an auditor with Deloitte & Touche, LLP for three years and spent four years in the United States Navy. Mr. Smith holds a Bachelor’s of Science in Accounting from the University of Illinois and holds a license as a Certified Public Accountant CPA.
TrentN.Smith自2016年8月起担任公司执行Vice President兼首席会计官。在2016年8月之前,史密斯先生担任公司的Vice President兼公司财务总监,并继续担任公司财务总监。加入公司之前,Smith从2010年到2011年担任Syncreon Holdings外部报告主管,在此之前,从2006年到2010年担任Champion Enterprises会计和财务报告主管。在Smith&8217;先生的职业生涯早期,他曾于2005年至2006年担任Dura Automotive的外部财务报告总监,并于1999年至2005年担任Valeo,Inc.的内部控制/财务总监。在1999年之前,Smith先生在德勤会计师事务所(Deloitte&Touche,LLP)担任了三年的审计师,并在美国海军任职四年。Smith先生拥有伊利诺伊大学(University of Illinois)会计学理学学士学位,并持有注册会计师执照。
Trent N. Smith has served as the Company’s Executive Vice President and Chief Accounting Officer since August 2016. Prior to August 2016 Mr. Smith served as the Company’s Vice President and Corporate Controller, and he continues to serve as Corporate Controller. Prior to joining the Company, Mr. Smith served Syncreon Holdings from 2010 through 2011 as Director of External Reporting, and prior to that served Champion Enterprises as Director of Accounting and Financial Reporting from 2006 until 2010. Earlier in Mr. Smith’s career, he served as Director of External Financial Reporting for Dura Automotive from 2005 until 2006 and Valeo, Inc. as Director of Internal Controls/Finance from 1999 until 2005. Prior to 1999 Mr. Smith worked as an auditor with Deloitte & Touche, LLP for three years and spent four years in the United States Navy. Mr. Smith holds a Bachelor’s of Science in Accounting from the University of Illinois and holds a license as a Certified Public Accountant CPA.
Rich DiIorio

Rich DiIorio自2016年12月起担任公司肿瘤销售执行Vice President,并自2017年5月18日起担任总裁办公室成员,如上文“董事会和董事会委员会”所述。此前,Diiorio先生曾在Infusystem公司担任区域Vice President和地区经理,并在该公司获得无数奖项和荣誉。在加入公司之前,Diiorio先生在Stryker,Novartis和Thermo Scientific担任过各种销售和销售领导职务。


Rich DiIorio has served as the Company's Executive Vice President of Oncology Sales since December 2016 and has served as a member of the Office of the President, as described under "Board of Directors and Committees of the Board of Directors" above, since May 18 2017. Previously, Mr. DiIorio held the positions of Regional Vice President and Territory Manager at InfuSystem where he received numerous awards and honors. Prior to joining the Company, Mr. DiIorio held various sales and sales leadership roles at Stryker, Novartis, and Thermo Scientific.
Rich DiIorio自2016年12月起担任公司肿瘤销售执行Vice President,并自2017年5月18日起担任总裁办公室成员,如上文“董事会和董事会委员会”所述。此前,Diiorio先生曾在Infusystem公司担任区域Vice President和地区经理,并在该公司获得无数奖项和荣誉。在加入公司之前,Diiorio先生在Stryker,Novartis和Thermo Scientific担任过各种销售和销售领导职务。
Rich DiIorio has served as the Company's Executive Vice President of Oncology Sales since December 2016 and has served as a member of the Office of the President, as described under "Board of Directors and Committees of the Board of Directors" above, since May 18 2017. Previously, Mr. DiIorio held the positions of Regional Vice President and Territory Manager at InfuSystem where he received numerous awards and honors. Prior to joining the Company, Mr. DiIorio held various sales and sales leadership roles at Stryker, Novartis, and Thermo Scientific.
Janet Skonieczny

2013年1月,Janet Skonieczny担任公司的首席运营官。2007年11月至2013年,她担任公司的营运副总裁、合规官员和私人侦探。自1998年以来,她担任InfuSystem公司的营运副总裁,一家全资附属公司。此外,从1997年到2012年5月,她担任公司秘书。在她的任期内,她推动和完成了第三方支付,协助这些项目与库存和跟踪系统的整合以及发展公司法规和保密程序。从1988年到1994年,她担任办公室经理。从1990年到1998年,她担任风险医疗业务经理,InfuSystem的前身公司,1988年开始经营。在Venture Medical公司,她在一些业务领域担任管理职位,包括Nova Healthcare Industries,一家镜鞘保护工具生产和设计公司,其用于妇科手术。Medical Reimbursement Solutions,一家第三方支付公司,为了输液中心、医生和医院进行设计和传输计费。Aventric医疗公司,一家中西部地区高科技设备,如心脏起搏器、心脏成像设备和药物输送系统的分销商。她拥有费里斯州立大学科学学位。她也是一名认证的心血管技术专家(CCVT)。


Janet Skonieczny became the Company’s Chief Operating Officer in January 2013 and Executive Vice President in November 2014 and has served as a member of the Office of the President, as described under “Board of Directors and Committees of the Board of Directors” above, since May 18 2017. Prior to 2013 she served as the Company’s Vice President of Operations, Compliance Officer and Privacy Officer since November 2007 and as Vice President of Operations of InfuSystem, Inc., the Company’s wholly-owned subsidiary, since 1998. Further, she served as the Company’s Corporate Secretary from 1997 to May 2012. During her tenure, she has facilitated the development and implementation of third party billing programs, assisted in the integration of those programs with inventory and tracking systems and led the development and implementation of the Company’s Compliance and Privacy Programs. From 1988 until 1994 she was Office Manager, and from 1990 until 1998 Operations Manager for Venture Medical, a predecessor company to InfuSystem, Inc., which commenced business operations in 1988. At Venture Medical, she played key managerial roles in several business, including Nova Healthcare Industries, a manufacturer and designer of speculum sheath protectors used in gynecologic procedures, Medical Reimbursement Solutions, a third-party billing company that formatted and transmitted billing claims on behalf of infusion centers, physicians and hospitals and Aventric Medical, Inc., a Midwest distributor of high-tech equipment such as pacemakers, cardiac imaging devices and drug delivery systems. Ms. Skonieczny has an Associates in Science AS degree from Ferris State University and is certified as a Cardiovascular Technologist (CCVT).
2013年1月,Janet Skonieczny担任公司的首席运营官。2007年11月至2013年,她担任公司的营运副总裁、合规官员和私人侦探。自1998年以来,她担任InfuSystem公司的营运副总裁,一家全资附属公司。此外,从1997年到2012年5月,她担任公司秘书。在她的任期内,她推动和完成了第三方支付,协助这些项目与库存和跟踪系统的整合以及发展公司法规和保密程序。从1988年到1994年,她担任办公室经理。从1990年到1998年,她担任风险医疗业务经理,InfuSystem的前身公司,1988年开始经营。在Venture Medical公司,她在一些业务领域担任管理职位,包括Nova Healthcare Industries,一家镜鞘保护工具生产和设计公司,其用于妇科手术。Medical Reimbursement Solutions,一家第三方支付公司,为了输液中心、医生和医院进行设计和传输计费。Aventric医疗公司,一家中西部地区高科技设备,如心脏起搏器、心脏成像设备和药物输送系统的分销商。她拥有费里斯州立大学科学学位。她也是一名认证的心血管技术专家(CCVT)。
Janet Skonieczny became the Company’s Chief Operating Officer in January 2013 and Executive Vice President in November 2014 and has served as a member of the Office of the President, as described under “Board of Directors and Committees of the Board of Directors” above, since May 18 2017. Prior to 2013 she served as the Company’s Vice President of Operations, Compliance Officer and Privacy Officer since November 2007 and as Vice President of Operations of InfuSystem, Inc., the Company’s wholly-owned subsidiary, since 1998. Further, she served as the Company’s Corporate Secretary from 1997 to May 2012. During her tenure, she has facilitated the development and implementation of third party billing programs, assisted in the integration of those programs with inventory and tracking systems and led the development and implementation of the Company’s Compliance and Privacy Programs. From 1988 until 1994 she was Office Manager, and from 1990 until 1998 Operations Manager for Venture Medical, a predecessor company to InfuSystem, Inc., which commenced business operations in 1988. At Venture Medical, she played key managerial roles in several business, including Nova Healthcare Industries, a manufacturer and designer of speculum sheath protectors used in gynecologic procedures, Medical Reimbursement Solutions, a third-party billing company that formatted and transmitted billing claims on behalf of infusion centers, physicians and hospitals and Aventric Medical, Inc., a Midwest distributor of high-tech equipment such as pacemakers, cardiac imaging devices and drug delivery systems. Ms. Skonieczny has an Associates in Science AS degree from Ferris State University and is certified as a Cardiovascular Technologist (CCVT).
Mike McReynolds

2013年4月以来,Mike McReynolds担任公司的首席信息官。任命之前,从2012年到2013年,他担任OxiArmor 的总裁,一家全国行的抗菌服务方案提供商,在感染控制到医疗、商业和住宅市场方面提供新技术。之前,从2006年到2011年,他担任RecoverCare的首席信息官,一家减肥支持表面、治疗支持表面、伤口护理和患者安全处理设备的全国供应商。他促进了一个基于伤口跟踪软件和集成EDI订购和计费的大型客户网站的发展。他拥有恩波利亚州立大学的工商管理学士学位。


Mike McReynolds has served as the Company's Chief Information Officer since April 2013 and Executive Vice President since November 2014. Prior to this appointment, Mr. McReynolds served as President of OxiArmor, LLC, a nationwide provider of solutions-based antimicrobial service that offers new technology within Infection Control to healthcare, commercial and residential markets from 2012 to 2013. Prior to that, Mr. McReynolds served as Chief Information Officer of RecoverCare, LLC, a nationwide provider of Bariatric Support Surfaces, Therapeutic Support Surfaces, Wound Care and Safe Patient Handling Equipment, from 2006 to 2011 where he facilitated the development of a web based Wound Tracking Software and integrated multiple large clients with EDI ordering and billing. Mr. McReynolds earned his B.S. in Business Administration from Emporia State University.
2013年4月以来,Mike McReynolds担任公司的首席信息官。任命之前,从2012年到2013年,他担任OxiArmor 的总裁,一家全国行的抗菌服务方案提供商,在感染控制到医疗、商业和住宅市场方面提供新技术。之前,从2006年到2011年,他担任RecoverCare的首席信息官,一家减肥支持表面、治疗支持表面、伤口护理和患者安全处理设备的全国供应商。他促进了一个基于伤口跟踪软件和集成EDI订购和计费的大型客户网站的发展。他拥有恩波利亚州立大学的工商管理学士学位。
Mike McReynolds has served as the Company's Chief Information Officer since April 2013 and Executive Vice President since November 2014. Prior to this appointment, Mr. McReynolds served as President of OxiArmor, LLC, a nationwide provider of solutions-based antimicrobial service that offers new technology within Infection Control to healthcare, commercial and residential markets from 2012 to 2013. Prior to that, Mr. McReynolds served as Chief Information Officer of RecoverCare, LLC, a nationwide provider of Bariatric Support Surfaces, Therapeutic Support Surfaces, Wound Care and Safe Patient Handling Equipment, from 2006 to 2011 where he facilitated the development of a web based Wound Tracking Software and integrated multiple large clients with EDI ordering and billing. Mr. McReynolds earned his B.S. in Business Administration from Emporia State University.